Guardant Health Inc
F:5GH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guardant Health Inc
F:5GH
|
US |
|
B&M European Value Retail SA
LSE:BME
|
LU |
|
Nel ASA
OSE:NEL
|
NO |
|
A
|
Asia Fiber PCL
SET:AFC
|
TH |
|
Davide Campari Milano NV
MIL:CPR
|
IT |
|
K
|
Kingfish Company NV
OSE:KING
|
NL |
|
M
|
Metals X Ltd
F:FG5
|
AU |
Intrinsic Value
Is 5GH undervalued or overvalued?
See the intrinsic value estimate for 
Guardant Health Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
5GH looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 5GH’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Guardant Health Does
Guardant Health makes blood-based tests for cancer. Its main products are liquid biopsy tests that look for tumor DNA in a patient’s blood, helping doctors detect cancer, choose treatment, and watch for signs that disease may be returning. The company sells these tests to oncologists, hospitals, health systems, and patients through the medical care process.
- Headquarters
- United States of America US
- Employees
- 2 498
- IPO date
- Oct 4, 2018
Revenue & Expenses Breakdown
Guardant Health Inc
Earnings Waterfall
Guardant Health Inc
The intrinsic value for Guardant Health Inc (5GH) under the Base Case is hidden EUR.
Compared with the current market price of 145.56 EUR, the stock appears hidden.